HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Hyoung Kang Selected Research

CINK4

7/2013A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRAS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Hyoung Kang Research Topics

Disease

26Neoplasms (Cancer)
07/2021 - 09/2004
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 02/2010
9Disease Progression
07/2021 - 03/2016
6Lung Neoplasms (Lung Cancer)
10/2021 - 11/2009
5Squamous Cell Carcinoma of Head and Neck
10/2020 - 08/2013
5Neoplasm Metastasis (Metastasis)
01/2020 - 01/2012
4Neutropenia
01/2019 - 01/2014
4Carcinoma (Carcinomatosis)
01/2014 - 09/2004
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 01/2012
3Nausea
10/2017 - 07/2015
3Adenocarcinoma
05/2016 - 01/2005
3Head and Neck Neoplasms (Head and Neck Cancer)
10/2015 - 08/2009
2Hemorrhage
01/2021 - 06/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2020 - 05/2016
2Anemia
01/2020 - 07/2015
2Diarrhea
01/2019 - 12/2013
2Exanthema (Rash)
10/2017 - 12/2013
2Adenocarcinoma of Lung
07/2013 - 11/2012
2Carcinogenesis
04/2012 - 01/2007
2Stomach Neoplasms (Stomach Cancer)
08/2010 - 09/2004
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2008 - 06/2008
2Cholangiocarcinoma
09/2004 - 06/2004
1Brain Neoplasms (Brain Tumor)
07/2021
1Hypoxia (Hypoxemia)
11/2020
1Necrosis
11/2020
1Nephritis
01/2018
1Pruritus (Itching)
10/2017
1Stomatitis
10/2017
1Fatigue
10/2017
1Pulmonary Embolism
12/2016
1Thrombocytopenia (Thrombopenia)
12/2016
1Febrile Neutropenia
10/2016
1Vomiting
12/2015

Drug/Important Bio-Agent (IBA)

11ErbB Receptors (EGF Receptor)IBA
01/2021 - 09/2004
10Tyrosine Kinase InhibitorsIBA
07/2021 - 10/2011
10Docetaxel (Taxotere)FDA Link
02/2020 - 02/2010
10Cisplatin (Platino)FDA LinkGeneric
04/2019 - 06/2004
7PlatinumIBA
02/2020 - 02/2010
4Fluorouracil (Carac)FDA LinkGeneric
08/2010 - 06/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 06/2008
3Proteins (Proteins, Gene)FDA Link
11/2020 - 09/2010
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2020 - 05/2013
3Gefitinib (Iressa)FDA Link
08/2012 - 09/2004
2NivolumabIBA
10/2020 - 10/2017
2osimertinibIBA
01/2020 - 12/2016
2Pemetrexed (MTA)FDA Link
04/2019 - 08/2012
2Pharmaceutical PreparationsIBA
01/2019 - 09/2010
2Messenger RNA (mRNA)IBA
01/2019 - 09/2010
2SteroidsIBA
12/2016 - 12/2015
2Cyclin D1IBA
07/2013 - 09/2010
2Paclitaxel (Taxol)FDA LinkGeneric
07/2013 - 09/2004
2Carcinoembryonic AntigenIBA
08/2012 - 06/2008
2AntigensIBA
08/2012 - 06/2008
2GemcitabineFDA Link
12/2011 - 09/2004
2Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2006 - 09/2004
2Epirubicin (Ellence)FDA LinkGeneric
01/2005 - 06/2004
1Taxoids (Taxanes)IBA
10/2021
1AfatinibIBA
07/2021
1olmutinibIBA
01/2021
1CamptothecinIBA
01/2021
1belotecanIBA
01/2021
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2021
1AnticoagulantsIBA
01/2021
1Topotecan (Hycamtin)FDA LinkGeneric
01/2021
1Hematoxylin (Haematoxylon)IBA
11/2020
1pimonidazoleIBA
11/2020
1N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamideIBA
11/2020
1Eosine Yellowish-(YS) (Eosin)IBA
11/2020
1TubulinIBA
11/2020
1Darbepoetin alfa (Aranesp)FDA Link
01/2020
1Beclin-1IBA
03/2019
1ParaffinIBA
01/2019
1nintedanibIBA
01/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2019
1Irinotecan (Camptosar)FDA LinkGeneric
01/2019
1Etoposide (VP 16)FDA LinkGeneric
01/2019
1naquotinibIBA
09/2018
1KinesinsIBA
03/2018
1Technetium Tc 99m Dimercaptosuccinic AcidIBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2017
1Alanine Transaminase (SGPT)IBA
12/2016
1RamucirumabIBA
10/2016
1Matrix Metalloproteinases (MMPs)IBA
05/2016
1Tissue Inhibitor of Metalloproteinase-1IBA
05/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2016
1Serotonin ReceptorsIBA
12/2015
1ramosetron (Nasea)IBA
12/2015
1Aprepitant (Emend)FDA Link
12/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2015
1Ondansetron (Zofran)FDA LinkGeneric
12/2015
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
12/2015
1Cetuximab (Erbitux)FDA Link
10/2015

Therapy/Procedure

14Therapeutics
01/2021 - 12/2009
14Drug Therapy (Chemotherapy)
01/2020 - 06/2004
7Radiotherapy
11/2020 - 06/2008
5Induction Chemotherapy
02/2020 - 12/2009
5Chemoradiotherapy
09/2019 - 06/2008
2Aftercare (After-Treatment)
11/2020 - 12/2011
2Consolidation Chemotherapy
08/2015 - 03/2011
2Combination Drug Therapy (Combination Chemotherapy)
12/2011 - 09/2004